Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2024 Dec 5:2024.12.03.24318413. [Version 1] doi: 10.1101/2024.12.03.24318413

The oral microbiome and all-cause mortality in the US population

Emily Vogtmann 1,*, Yukiko Yano 1,*, Jianxin Shi 1, Yunhu Wan 1,2, Vaishnavi Purandare 1, Jody McLean 3, Shilan Li 4, Rob Knight 5, Lisa Kahle 6, Autumn G Hullings 7, Xing Hua 1,2, Barry I Graubard 1, Maura L Gillison 8, J Gregory Caporaso 9, Nicholas A Bokulich 10, Martin J Blaser 11, Neal D Freedman 12, Anil K Chaturvedi 1,*, Christian C Abnet 1,*
PMCID: PMC11643182  PMID: 39677439

Abstract

Importance:

Poor oral health, including periodontal disease, is associated with oral microbiome changes and increased mortality risk. However, no large studies have evaluated whether the oral microbiome is directly associated with mortality.

Objective:

To evaluate whether measures of the oral microbiome is prospectively associated with all-cause mortality.

Design:

A cross-sectional survey with samples collected from 2009–2012 and mortality linkage to the restricted-use National Death Index (NDI) through 2019.

Setting:

The National Health and Nutrition Examination Survey (NHANES) 2009–2012, a multistage probability sample of the US population.

Participants:

NHANES participants 20- to 69-years-old who were eligible for linkage to the NDI and provided oral rinse specimens (N=7,721, representing approximately 194 million individuals).

Exposure:

Oral microbiome ascertained by sequencing the V4 region of the 16S rRNA gene of extracted DNA from oral rinse specimens. Alpha diversity, beta diversity, and genus-level data were generated using DADA2 and QIIME.

Main outcome and measure:

All-cause mortality.

Results:

After an average of 8.8 years, a total of 426 participants died. Using Cox proportional hazards regression and after controlling for multiple comparisons where appropriate, continuous alpha diversity was inversely associated with all-cause mortality, but only the association for the Shannon-Weiner index was significant with full adjustment for major risk factors (hazard ratio [HR] per standard deviation [SD]=0.85; 95% confidence interval [CI]=0.74–0.98). The principal coordinate analysis (PCoA) vector 2 from the Bray-Curtis dissimilarity matrix (HR per SD=0.83; 95% CI=0.73–0.93) and PCoA1 from weighted UniFrac (HR per SD=0.86; 95% CI=0.75–0.98) were significantly associated with all-cause mortality after full adjustment. Few associations were observed at the genus-level after Bonferroni correction, but an increase in 1 SD of the relative abundance of Granulicatella and Lactobacillus were associated with a 17% (95% CI=1.11–1.24) and 11% (95% CI=1.06–1.16) increase in mortality risk, respectively. Compared to participants with no detectable Bacteroides, participants in the highest tertile of Bacteroides had decreased mortality risk (HR=0.54; 95% CI=0.40–0.74).

Conclusions and relevance:

Some measures of the oral microbiome were associated with all-cause mortality in this representative population cohort. These results suggest that oral bacterial communities may be important contributors to health and disease.

Introduction

The oral microbiome serves multiple functions in human health, locally and systemically. Specific oral microbes are closely linked to periodontal disease,1 and many others are associated with oral health conditions such as caries.2 The oral microbiome also has been associated with cardiovascular disease3 and multiple site-specific cancers including lung cancer.4 These microorganisms also play a central role in the metabolism of ethanol to its carcinogenic intermediate acetaldehyde.5 The oral microbiome may be related to mortality, as previous studies have identified associations between oral health conditions and mortality,6,7 but no large studies of the oral microbiome including genus-level taxonomy have been conducted to directly investigate mortality associations.

We analyzed associations between the oral microbiome from participants aged 20–69 years in the 2009–2012 cycles of the National Health and Nutrition Examination Survey (NHANES)8 and all-cause mortality from linkage to the National Death Index (NDI) while controlling for numerous potential confounders.

Methods

NHANES is a continuous survey conducted by the National Center for Health Statistics (NCHS) to characterize the health and nutritional status of the US population. Participants are interviewed about demographics, diet, and other health-related data and then visit a mobile examination center (MEC) for biospecimen collection and health examinations.9 NDI mortality data through December 31, 2019 were available for eligible adult participants from the NCHS restricted-use linked mortality file.10

From 2009–2012, oral rinse samples were collected from participants aged 14–69 years which were used for microbiome analyses. After DNA extraction,11 the V4 region of the 16S rRNA gene was PCR amplified and sequenced. Sequencing data were processed using DADA2 and QIIME and taxonomy was assigned using the SILVA v123 database. After removal of the amplicon sequencing variant (ASV) SV1032, a human pseudogene, alpha and beta diversity metrics were generated at an even sampling depth of 10,000 reads per sample.12

As fully described in the companion manuscript (MEDRXIV/2024/318415), we incorporated many potential confounders in our analysis, including continuous age and spline variables for non-linear age relationships, sex, self-identified race and ethnicity categories grouped by NHANES standard practice, education, marital status, and the income-to-poverty ratio. Detailed categories of self-reported lifetime cigarette smoking history and alcohol consumption were used. Periodontal disease status, tooth counts, and body mass index categories were calculated based on health examinations. We included self-reported use of prescription medications, including antibiotics, anti-lipidemic drugs, inhaled respiratory drugs, and drugs for treatment of gastroesophageal reflux disease. Finally, we determined each participant’s diabetes and hypertension status using self-report, laboratory and examination data.

Analyses were restricted to MEC participants, aged 20–69 years with microbiome and NDI data (N=7,721, representing approximately 194 million people). We presented the characteristics of the population by mortality status and estimated hazard ratios (HR) and 95% confidence intervals (CI) for these characteristics from multivariable Cox proportional hazards models with time since the MEC visit as the underlying time metric. We estimated HRs for the association between the alpha diversity metrics (observed ASVs, Faith’s phylogenetic diversity [PD], Shannon-Weiner index, and Simpson index) and principal coordinate analysis (PCoA) vectors from the beta diversity matrices (unweighted UniFrac, weighted UniFrac, and Bray-Curtis). We estimated HRs for genus-level presence, relative abundance, centered log-ratio (CLR) transformed abundances, and a combined variable incorporating both the presence and tertiles of relative abundance. Bonferroni-adjusted p-values cutpoints were determined for genus-level models. We used SAS and SUDAAN and incorporated the complex survey design, including post-stratification weights.

Results

After an average of 8.8 years of follow-up, a total of 426 participants died, including 135 deaths from malignant neoplasms and 91 from heart diseases. Participants who died were more likely to be older, male, experiencing poverty, categorized with Class 2 or 3 obesity, and have periodontal disease or edentulism (Table 1).

Table 1.

Selected characteristics of participants and associations with overall mortality in the linked oral microbiome and mortality NHANES files 2009–2012

Died over follow-up Alive at the end of follow-up
N = 426 N = 7,295
N (Weighted %) N (Weighted %) HR (95% CI)
Age groups (years)
20–29 22 5.44% 1,637 22.26% Ref
30–39 25 6.30% 1,545 20.85% 1.13 (0.56, 2.28)
40–49 58 15.73% 1,532 22.24% 2.38 (1.10, 5.15)
50–59 124 33.42% 1,318 20.80% 5.33 (2.39, 11.86)
60–69 197 39.11% 1,263 13.85% 9.47 (4.41, 20.36)
Sex
Male 271 65.51% 3,552 48.10% Ref
Female 155 34.49% 3,743 51.90% 0.48 (0.37, 0.61)
Self-reported race and ethnicity
Mexican American 55 6.50% 1,217 9.20% 0.62 (0.42, 0.91)
Other Hispanic 35 2.83% 768 6.00% 0.47 (0.27, 0.82)
Non-Hispanic Black 125 15.16% 1,681 11.72% 0.90 (0.66, 1.23)
Non-Hispanic White 186 71.36% 2,738 64.81% Ref
Non-Hispanic other race including multiracial 25 4.15% 891 8.28% 0.45 (0.26, 0.78)
Education
Less than high school 161 28.46% 1,703 15.76% Ref
Completed high school/GED 99 24.61% 1,581 20.57% 0.89 (0.56, 1.39)
More than high schoolA 166 46.93% 4,011 63.66% 0.80 (0.58, 1.11)
Marital status
Never married 68 16.95% 1,693 21.06% Ref
Married/living with partnerA 224 59.74% 4,328 63.57% 0.65 (0.39, 1.09)
Divorced/widowed/separated 134 23.31% 1,274 15.37% 0.63 (0.35, 1.17)
Income-to-poverty ratioA
High poverty (<1) 128 22.23% 1,660 15.56% 1.78 (1.32, 2.40)
Medium poverty (1–1.999) 135 23.10% 1,723 17.99% 1.47 (1.05, 2.05)
Low poverty (2–2.999) 45 13.74% 853 12.86% 1.39 (0.84, 2.30)
Very low poverty (≥3) 88 34.14% 2,459 47.03% Ref
Missing 30 6.80% 600 6.56% 1.19 (0.68, 2.09)
Body mass index (kg/m2)
<18.5 (Underweight) 12 3.86% 112 1.59% 3.49 (1.31, 9.33)
18.5–24.999 (Normal weight)B 109 21.16% 2,091 29.99% Ref
25–29.999 (Overweight) 126 31.15% 2,368 32.98% 1.18 (0.77, 1.80)
30–34.999 (Class 1 obesity) 83 19.41% 1,510 20.46% 1.09 (0.75, 1.60)
≥35 (Class 2 & 3 obesity) 96 24.41% 1,214 14.97% 2.01 (1.35, 2.99)
Cigarette smoking history
Never smoker 152 34.74% 4,221 57.36% Ref
CurrentC smokers ≤10 cigs/day 81 17.21% 1,065 12.67% 1.85 (1.20, 2.86)
CurrentC smokers 11–20 cigs/day 69 16.79% 497 7.08% 1.89 (1.17,3.05)
CurrentC smokers >20 cigs/day 22 5.42% 146 2.37% 1.53 (0.74, 3.15)
CurrentC smokers, intensity unknown 10 3.31% 156 2.34% 1.67 (0.83, 3.33)
Former smokers, quit 1–10 years ago, smoked ≤10 cigs/dayD 19 3.59% 293 4.10% 1.28 (0.54, 3.05)
Former smokers, quit 1–10 years ago, smoked 11-20 cigs/day 14 5.13% 105 1.59% 3.44 (1.71, 6.91)
Former smokers, quit 1–10 years ago, smoked >20 cigs/day 12 3.54% 68 0.96% 1.20 (0.46, 3.12)
Former smokers, quit ≥10 years ago, smoked ≤10 cigs/dayE 34 7.49% 380 5.28% 1.35 (0.80, 2.29)
Former smokers, quit ≥10 years ago, smoked >10 cigs/day 13 2.79% 364 6.25% 0.28 (0.13, 0.62)
Alcohol consumption
Never drinker 34 7.18% 807 8.50% Ref
Drinks 0 drinks/week in past 12 months 143 29.30% 969 11.95% 1.49 (0.92, 2.41)
Drinks >0-<1 drink/week in past 12 months 83 22.15% 2,145 28.75% 0.84 (0.47, 1.50)
Drinks 1-<8 drinks/week in past 12 months 63 15.47% 1,752 28.08% 0.64 (0.32, 1.26)
Drinks 8-<14 drinks/week in past 12 months 24 6.85% 484 8.02% 0.82 (0.39, 1.71)
Drinks ≥14 drinks/week in past 12 months 54 13.46% 485 7.19% 1.26 (0.75, 2.11)
Missing 25 5.58% 653 7.51% 1.00 (0.47, 2.12)
Periodontal disease/edentulism
No periodontal disease 72 19.61% 2,473 40.53% Ref
Mild periodontal disease 20 5.77% 343 4.43% 1.92 (0.86, 4.32)
Moderate periodontal disease 121 29.20% 1,597 18.81% 1.45 (0.94, 2.26)
Severe periodontal disease 68 14.30% 608 5.66% 1.98 (1.08, 3.61)
Not eligible for periodontal assessment (<30 years old) 22 5.44% 1,637 22.26% NA
EdentulousF 69 14.17% 202 2.15% 2.81 (1.61, 4.90)
Missing 54 11.51% 435 6.15% 1.62 (0.95, 2.76)
A

The income-to-poverty ratio is based on self-reported family income and the Department of Health and Human Services poverty guidelines

B

Includes missing (missing <5%)

C

Includes individuals who quit <1 year ago

D

Includes intensity unknown

E

Includes intensity unknown or missing quit years

F

Periodontal disease severity is calculated only for dentate adults

The weighted percentage estimates may be imprecise for small cell sizes. Hazard ratio (HR) and 95% confidence interval (CI) calculated from a Cox proportional hazards model using linked mortality data including all listed variables. The HR for the individuals who were not eligible for the periodontal disease examination is not presented because it is the same as the 20–29 year age group variable.

All continuous alpha diversity metrics were inversely associated with all-cause mortality after minimal adjustment (e.g., HRObserved ASVs per SD=0.82; 95% CI=0.68–0.98), but associations were attenuated after full adjustment (Figure 1 and Supplemental Table 1). In fully adjusted models, only the Shannon-Weiner index association remained statistically significant (HR per SD=0.85; 95% CI=0.74–0.98). The associations for quartiles of alpha diversity were inverse, but only the association for the highest quartile for the Simpson index reached statistical significance (HRQ4=0.62; 95% CI=0.39–0.99; Supplemental Table 1). For beta diversity, PCoA2 from the Bray-Curtis dissimilarity (HR per SD=0.83; 95% CI=0.73–0.93) and PCoA1 from weighted UniFrac (HR per SD=0.86; 95% CI=0.75–0.98) matrices were statistically significantly associated with all-cause mortality after full adjustment (Figure 1 and Supplemental Table 1).

Figure 1. Forest plot of the estimated hazard ratios (HR) with 95% confidence intervals and p-values for the associations of alpha diversity (i.e., observed amplicon sequence variants [ASV], Faith’s Phylogenetic Diversity [PD], Shannon Weiner, and Simpson indices), beta diversity (i.e., Bray-Curtis, unweighted UniFrac, and weighted UniFrac) principal coordinate analysis (PCoA) vectors, and specific genera with all-cause mortality in the linked oral microbiome and mortality NHANES files 2009–2012.

Figure 1.

The Cox proportional hazards models included adjustment for age, age splines, sex, self-reported race and ethnicity as categorized by NHANES, education, marital status, income-to-poverty ratio, body mass index category, detailed smoking history, alcohol consumption, periodontal disease/edentulism, prevalent diabetes or hypertension, and use of prescription medications for antibiotics, anti-lipidemic drugs, inhaled respiratory drugs, and drugs for treatment of gastroesophageal reflux disease. Alpha diversity, beta diversity, relative abundance, and centered log-ratio (CLR) transformed abundance associations were modeled as the per standard deviation change in the estimate. For the presence analysis, no genera were significantly associated with all-cause mortality at a Bonferroni adjusted p-value (p-value < 0.05/133 = 0.0004), but genera with a p-value less than 0.01 are presented. All of the calculated genus-level presence associations are included in Supplemental Table 2. For the relative abundance analysis, two genera were statistically significant at the Bonferroni adjusted p-value (p-value < 0.05/103 = 0.0005) and genera with a p-value less than 0.01 are presented. All of the calculated genus-level relative abundance associations are included in Supplemental Table 3. For the CLR-transformed abundance analysis, no genera were significantly associated with all-cause mortality at a Bonferroni adjusted p-value (p-value < 0.05/103 = 0.0005), but genera with a p-value less than 0.01 are presented. All of the calculated genus-level CLR-transformed abundance associations are included in Supplemental Table 4.

After Bonferroni correction, none of the genus-level presence associations were statistically significant in fully adjusted models, although some strong associations were noted (Figure 1 and Supplemental Table 2). For relative abundance, each SD increase in Granulicatella or Lactobacillus was associated with 1.17 (95% CI=1.11–1.24) and 1.11 (95% CI=1.06–1.16) times the mortality risk, respectively, which remained statistically significant after Bonferroni correction (Figure 1 and Supplemental Table 3). However, none of the CLR-transformed abundances were statistically significant in fully adjusted models, although the association with Lactobacillus was similar to the relative abundance analysis (HR 1.13; 95% CI: 0.99–1.28; Figure 1 and Supplemental Table 4). In the combined presence and relative abundance analysis, compared to participants with no Bacteroides detected, participants in the highest tertile had reduced mortality risk (HR=0.54; 95% CI=0.40–0.74; ptrend=0.0001; Figure 2 and Supplemental Table 5).

Figure 2. Forest plot of the estimated hazard ratios (HR) with 95% confidence intervals and p-values for the associations of the combined genus-level presence and relative abundance with all-cause mortality in the oral microbiome and linked mortality NHANES files 2009–2012.

Figure 2.

The Cox proportional hazards models included adjustment for age, age splines, sex, self-reported race and ethnicity as categorized by NHANES, education, marital status, income-to-poverty ratio, body mass index category, detailed smoking history, alcohol consumption, periodontal disease/edentulism, prevalent diabetes or hypertension, and use of antibiotics, anti-lipidemic drugs, inhaled respiratory drugs, and prescription drugs for treatment of gastroesophageal reflux disease. The reference value is the absence of the specific genus compared to the calculated tertiles of relative abundance for that genus. For the p-value of the trend, only Bacteroides with a p-trend of 0.0001 was statistically significant at the Bonferroni adjusted p-value (p-value < 0.05/83 = 0.0006), but genera with a p-value less than 0.01 for the association with any tertile are presented. All of the calculated combined genus-level associations are included in Supplemental Table 5.

Discussion

We found some oral microbial population characteristics to be independently associated with all-cause mortality in this large, representative cohort of the 20- to 69-year-old US population. The alpha diversity measures incorporating richness and evenness (i.e., the Shannon and Simpson indices) were significantly inversely associated with mortality. Some significant associations were also observed with the beta diversity matrices which incorporate the relative abundance of the ASVs (i.e., Bray-Curtis and weighted UniFrac) which suggests that the oral microbial community itself may be related to health and disease. At the genus-level, a higher relative abundance of Granulicatella and Lactobacillus were associated with increased all-cause mortality, while compared with individuals without detectable Bacteroides, a high relative abundance of Bacteroides was associated with decreased all-cause mortality. These three genera are common oral species, but Granulicatella has been associated with endocarditis and bacteremia,13 Lactobacillus has been associated with increased risk of lung cancer,4 and Bacteroides has been implicated in periodontal disease1 and health.14

This study has important strengths as it is representative of the adult US population and prospective in nature with relatively long follow-up from NDI linkage. We included thorough adjustment for many confounders, particularly measured periodontal disease status and edentulism, which provides strong evidence for independent microbiome associations. However, there are some limitations to note. Due to the use of 16S rRNA gene sequencing, we were only able to accurately assign the bacterial taxa to the genus-level. The use of shotgun metagenomics in future studies would allow for more granular and imputed functional associations. There were also relatively few deaths over the follow-up, which precluded the study of cause-specific mortality outcomes. Finally, there is the possibility for residual confounding from unmeasured or uncontrolled factors.

In conclusion, some measures of the oral microbiome were independently associated with all-cause mortality in a nationally representative US cohort. Our findings highlight the importance of the oral microbiome and oral health to overall human health and more research could lead to a greater understanding of these associations.

Supplementary Material

Supplement 1
media-1.xlsx (85.9KB, xlsx)

Key points.

Question:

Does the human oral microbiome impact an individual’s risk of mortality?

Findings:

In this prospective study including 7,721 individuals of which 426 died over follow-up, specific measures of the oral microbiome were associated with all-cause mortality.

Meaning:

The microbes living in the oral cavity may play an important role in human health.

Acknowledgements

We would like to acknowledge Gail Ackermann, Amnon Amir, James Gaffney, Grant Gogul, Greg Humphrey, Tara Schwartz, and Weihong Xiao for their role in project management and data production. This study was supported in part by a grant from the National Institute for Dental and Craniofacial Research (R01DE023175), a grant from the US Food and Drug Administration’s Center for Tobacco Products, a grant from the National Cancer Institute Informatics Technology for Cancer Research (1U24CA248454–01), the Intramural Research Program of the National Cancer Institute, and Federal funds from the National Cancer Institute, National Institutes of Health, under NCI Contract number 75N910D00024. We also acknowledge the research contributions of the Cancer Genomics Research Laboratory for their expertise, execution, and support of this research in the bioinformatics analysis of generated data. The content of this publication are those of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services or the official position of the Centers for Disease Control and Prevention. The mention of trade names, commercial products, or organizations does not imply endorsement by the US Government.

Data sharing statement

Unlinked public-use National Health and Nutrition Examination Survey (NHANES) data files are available on the NHANES website (https://www.cdc.gov/nchs/nhanes). The linked mortality (National Death Index) files are available in a public-use version, available online (https://www.cdc.gov/nchs/data-linkage/mortality.htm), and a restricted-use file available for analysis at the National Center for Health Statistics Research Data Center (https://www.cdc.gov/rdc/index.htm). The restricted-use mortality file was used for this analysis.

References

  • 1.Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. Feb 1998;25(2):134–44. doi: 10.1111/j.1600-051x.1998.tb02419.x [DOI] [PubMed] [Google Scholar]
  • 2.Costalonga M, Herzberg MC. The oral microbiome and the immunobiology of periodontal disease and caries. Immunology letters. 2014;162(2):22–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Maki KA, Ganesan SM, Meeks B, et al. The role of the oral microbiome in smoking-related cardiovascular risk: a review of the literature exploring mechanisms and pathways. Journal of translational medicine. 2022;20(1):1–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Vogtmann E, Hua X, Yu G, et al. The Oral Microbiome and Lung Cancer Risk: An Analysis of 3 Prospective Cohort Studies. J Natl Cancer Inst. Nov 14 2022;114(11):1501–1510. doi: 10.1093/jnci/djac149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nieminen MT, Salaspuro M. Local Acetaldehyde-An Essential Role in Alcohol-Related Upper Gastrointestinal Tract Carcinogenesis. Cancers (Basel). Jan 5 2018;10(1)doi: 10.3390/cancers10010011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Garcia RI, Krall EA, Vokonas PS. Periodontal disease and mortality from all causes in the VA Dental Longitudinal Study. Annals of Periodontology. 1998;3(1):339–349. [DOI] [PubMed] [Google Scholar]
  • 7.Liu J, Zong X, Vogtmann E, et al. Tooth count, untreated caries and mortality in US adults: a population-based cohort study. Int J Epidemiol. Aug 10 2022;51(4):1291–1303. doi: 10.1093/ije/dyac072 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vogtmann E, Chaturvedi AK, Blaser MJ, et al. Representative oral microbiome data for the US population: the National Health and Nutrition Examination Survey. The Lancet Microbe. 2023;4(2):e60–e61. [DOI] [PubMed] [Google Scholar]
  • 9.National Center for Health Statistics. About the National Health and Nutrition Examination Survey. Updated 9/15/2017. Accessed 10/5, 2022. https://www.cdc.gov/nchs/nhanes/about_nhanes.htm
  • 10.National Center for Health Statistics. NCHS Data Linked to NDI Mortality Files. Accessed 7/15, 2024. https://www.cdc.gov/nchs/data-linkage/mortality.htm
  • 11.Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009–2010. Jama. Feb 15 2012;307(7):693–703. doi: 10.1001/jama.2012.101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.National Center for Health Statistics. National Health and Nutrition Examination Survey 2009–2010 and 2011–2012 Oral Microbiome Data Documentation. Updated 10/2022. Accessed 11/2, 2023. https://wwwn.cdc.gov/nchs/data/nhanes/omp/OralMicrobiomeDataDocumentation-508.pdf
  • 13.Cargill JS, Scott KS, Gascoyne-Binzi D, Sandoe JA. Granulicatella infection: diagnosis and management. Journal of medical microbiology. 2012;61(6):755–761. [DOI] [PubMed] [Google Scholar]
  • 14.Leys EJ, Lyons SR, Moeschberger ML, Rumpf RW, Griffen AL. Association of Bacteroides forsythus and a novel Bacteroides phylotype with periodontitis. Journal of clinical microbiology. 2002;40(3):821–825. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1
media-1.xlsx (85.9KB, xlsx)

Data Availability Statement

Unlinked public-use National Health and Nutrition Examination Survey (NHANES) data files are available on the NHANES website (https://www.cdc.gov/nchs/nhanes). The linked mortality (National Death Index) files are available in a public-use version, available online (https://www.cdc.gov/nchs/data-linkage/mortality.htm), and a restricted-use file available for analysis at the National Center for Health Statistics Research Data Center (https://www.cdc.gov/rdc/index.htm). The restricted-use mortality file was used for this analysis.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES